Effects of Physical Activity on Cardiovascular Risk and Quality of Life
A Randomized Community Trial of Physical Activity Intervention in Primary Healthcare to Improve Cardiovascular Risk Factors and Health-Related Quality of Life in Older Adults
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
* Adults users of 4 Primary Health Care Centers in Catalunya.
Exclusion Criteria:
- Previous episode of ischemic heart disease (<6 months).
- Outbreak of arthritis with limited ability to ambulate.
- Lung or heart disease with dyspnea mild-moderate efforts.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Physical, social and cultural activities
Physical Activity: The training program will be supervised by a physical activity specialist and will consiste of two aerobic exercise sessions per week, including walking and stretching exercises after walking. Each session will be 60 minutes and the size of groups will be from 15 to 30 participants. Additionally, participants will receive advice about the health benefits of PA and PHC nurses using different strategies to encourage the adherence of participants to the program. Social and cultural support activities. Activities will include: visits to museums and libraries, cultural exhibitions, tourist attractions and dance lessons. These activities will be performed once a month. |
This intervention included two 60-min aerobic exercise sessions per week.
Each session was supervised by a physical activity specialist and walking and stretching exercises were performed after programmed exercise sessions.
PHC nurses were prepared to advise patients about the health benefits of PA and used different strategies to encourage the adherence of participants to the program.
In addition, social and cultural support activities were included in this intervention program.
These activities were performed once a month and they included: visits to museums and libraries, cultural exhibitions, tourist attractions and dance lessons.
|
|
介入なし:Control Group
No intervention.
We will measure the variables at the begining and after 9 months.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Physical activity level
時間枠:At the begining of the intervention and after 9 months.
|
It will assess at baseline and final by using the short form of the International Physical Activity Questionnarie (IPAQ-S) validated in the Catalan population.
It provides a self-estimated number of hours dedicated to PA.
The categories are: low, moderate and vigorous physical activity.
IPAQ data will use to measure the total weekly Physical Activity level in metabolic equivalents (METs)/min/week by weighting time spent in each activity intensity level with an estimated metabolic equivalent (MET) energy expenditure
|
At the begining of the intervention and after 9 months.
|
|
Cardiovascular risk.
時間枠:At the begining of the intervention and after 9 months
|
All participants will be asked if they have ever been diagnosed of hypertension, type 2 diabetes, dyslipidemia, overweight or obesity.
Blood pressure will be measured with a sphygmomanometer after participants have been sitting quietly for at least five minutes; three recordings will be taken and the average of the second and third readings will be use.
The cardiovascular risk will be calculated for each participant using the REGICOR scale based on Framingham criteria standardized for the Spanish population .
|
At the begining of the intervention and after 9 months
|
|
Biochemical analysis.
時間枠:At the begining of the intervention and after 9 months.
|
The biochemical parameters to analyze will be: Triglycerides, total cholesterol, HDL- and LDL-cholesterol; glycated hemoglobin and glucose.
A unique study profile has been created to analyze all these parameters at the Tarraco laboratory (ISO9001:2000 certified ICS Tarragona laboratory).
Blood will be extracted by PHC nurses from the fasting users in the corresponding PCC at 8:00 am.
The same professional will take it to the central laboratory using the standard sample transport procedure between PCC and the central laboratory.
|
At the begining of the intervention and after 9 months.
|
|
Antropometric measurements.
時間枠:At the begining of the intervention and after 9 months.
|
Weight (kg) will be measured using a balance scale with the measurement taken to the nearest 0.1 kg.
Height (cm) will be measured using a balance scale with the measurement taken to the nearest 1 cm.
Weight and Height measurements will be then used to calculate the body mass index [BMI: Weight (kg)/ (Height) 2 (m2)].
Waist circumference (WC), will be measured finding the top of their hip bone and the bottom of their ribs.
Threfore, the tape measure will be placed in the middle between these points and wrapped around the waist.
|
At the begining of the intervention and after 9 months.
|
|
Frequency of food consumption
時間枠:At the begining of the intervention and after 9 months.
|
We will use a validated food frequency questionnaire to assess food consumption.
Participants will be asked to report the number of times per week or month that certain foods will be consumed (45-items).
Foods will be grouped according to their nutrient composition: dairy (milk, yogurt, dairy desserts, cheese); meat/fish/eggs (red, white, processed meat and cold meat, lean, fatty fish and shellfish); total cereals (rice, pasta, bread, breakfast cereals, legumes -all type-, chocolate, biscuits, pastries and candies); fruits/vegetables (salad, tomatoes; vegetables side dish: aubergine, courgette, mushrooms; green beans, chards, spinaches, fresh fruits and canned fruits); oils and beverages (sweetened beverages, fermented beverages and alcoholic beverages), then the amount of g/day of each item will be calculated from the ECA-REF study's reference values.
|
At the begining of the intervention and after 9 months.
|
|
Health related quality of life
時間枠:At the begining of the intervention and after 9 months.
|
It will assess at baseline and final of the intervention with the Spanish version of the 36-item Short Form Health Survey (SF-36).
It consists of 36 items used to measure health status and outcomes from the patient's point of view, including the following 8 health concepts: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, mental health.
Two summary measures, the physical component summary (PCS) and the mental component summary (MCS), are derived from the last 8 health scores.
Participant responses to each item gave a total numerical score which will transform to 0-100 scale, so that a higher score corresponds to a better health status.
|
At the begining of the intervention and after 9 months.
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Arija V, Villalobos F, Pedret R, Vinuesa A, Jovani D, Pascual G, Basora J. Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial. Health Qual Life Outcomes. 2018 Sep 14;16(1):184. doi: 10.1186/s12955-018-1008-6.
- Arija V, Villalobos F, Pedret R, Vinuesa A, Timon M, Basora T, Aguas D, Basora J; Pas-a-Pas research group. Effectiveness of a physical activity program on cardiovascular disease risk in adult primary health-care users: the "Pas-a-Pas" community intervention trial. BMC Public Health. 2017 Jun 15;17(1):576. doi: 10.1186/s12889-017-4485-3.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- P11/67
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。